Tech Company Financing Transactions
Ciliatech Funding Round
BNP Paribas, private investors and Kreaxi participated in a $3.8 million Series A funding round for Ciliatech. The financing was announced on 4/25/2023.
Transaction Overview
Company Name
Announced On
4/25/2023
Transaction Type
Venture Equity
Amount
$3,842,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to achieve key R&D milestones and fulfil the regulatory affairs requirements to obtain CE mark approval by the end of 2024. It will also continue its clinical research program. The recruitment and roll-out of a new trial, which will start in Q2, 2023 in Europe, will gather knowledge about the safety and performance of CID in various patient populations and clinical settings.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
178 Route de Cran Gevrier PAE Altaïs
Chavanod, 74650
FR
Chavanod, 74650
FR
Phone
Website
Email Address
Overview
Ciliatech, a medtech company specialized in ophthalmology, is developing a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects. This new standard in treating glaucoma is effectively safer, more efficient and longer lasting than any options available for patients today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Olivier Benoit
Browse more venture capital transactions:
Prev: 4/25/2023: Cyclic Materials venture capital transaction
Next: 4/25/2023: 8 Myles venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs